PARK2 encodes the ubiquitin E3 ligase Parkin, and was first identified as a gene associated with the pathogenesis of early-onset PD,1 but was later linked with a wide range of disorders, most notably cancer, where it is a bona fide haploinsufficient tumor suppressor.2 The gene discussed is PRKN; the disease is neoplasm.